Explore Your Genetic Profile with ChemoSNiP

Order a test

ChemoSNiP is an innovative test that uses an advanced scientific technique called pharmacogenomics to analyse how a patient’s body will respond to a specific drug.

ChemoSNiP analyses a blood sample to identify single nucleotide polymorphisms – variations in our DNA sequence that can affect if we develop cancer or if we respond to treatments with chemicals, drugs and other agents.

ChemoSNiP provides clinicians with a powerful insight into which drugs are most effective at treating cancer. The results provide a personalised analysis that can be used to provide the most effective combination of drugs and treatments available.

Sample of the report Order a test

Test Details

Sample Type

Buccal swabs or peripheral whole blood

Analysis period

Approx. 6–8 working days

Cancer type

All types of Cancers

Final results

10–12 days after sample's receipt

Sample Size

Two (2) Buccal swabs or 7–10 ml peripheral whole blood

Price*

725€

* The prices of the tests may be an issue of local additional taxes and value added taxes which are dependent of each country’s legislation. The prices may vary in areas that are under the jurisdiction of a distributor. These prices are for the tests only, and they do not include in-office fees such as consultation, blood draws, etc.

Find out more about the science behind RGCC tests

Can brain tumours also be tested with a blood sample?

No, due to the blood-brain barrier, tumour cells cannot enter the bloodstream. This means that we cannot obtain and isolate any tumour cells from the blood sample.

Is it possible to measure circulating tumour cells (CTC) in patients with lymphoma or leukaemia?

Yes, patients with lymphoma or leukaemia can use an RGCC test to measure the number of circulating tumour cells (CTC) they have.

Which test is the most comprehensive test?

The most comprehensive test is the “Onconomics Plus” test. This provides information on the sensitivity or resistance of the patient’s tumour cells to certain cancer drugs and shows options for targeted therapy or an alternative treatment method with organic substances. The test also contains information about the development of the tumour and its potential by identifying epigenetic tumour markers relevant for the therapy, which are crucial for the correct therapeutic approach.

How do online consultations work?

Online consultations will give you the opportunity to speak to any member of the RGCC Network at a time and place that is convenient to you. You will be able to choose from a shortlist of clinicians who best suit your needs.

Will online consultations take place via Zoom, Skype, or another method?

Your chosen clinician will be in touch to make the arrangements and choose the most convenient method.

Didn't find an answer to your question? Contact us directly.

Get in touch

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more